enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Valbenazine - Wikipedia

   en.wikipedia.org/wiki/Valbenazine

   Valbenazine, sold under the brand name Ingrezza, is a medication used to treat tardive dyskinesia. [1] It acts as a vesicular monoamine transporter 2 (VMAT2) inhibitor . [ 2 ]

3. US FDA approves Neurocrine Biosciences' movement disorder ...

   www.aol.com/news/neurocrine-biosciences-hunting...

   Ingrezza was first approved in 2017 in its oral capsule formulation to treat adults. The U.S. Food and Drug Administration (FDA) has approved the granule formulation of Neurocrine Biosciences ...

4. Neurocrine Biosciences Reports Mixed Q4 - AOL

   www.aol.com/finance/neurocrine-biosciences...

   Ingrezza continued to perform well in Q4, with net product sales reaching $615 million, marking a 23% year-over-year increase. This growth was primarily due to high patient demand and improved ...

5. Associated Wholesale Grocers - Wikipedia

   en.wikipedia.org/wiki/Associated_Wholesale_Grocers

   Associated Wholesale Grocers, Inc. (AWG) is a retailer-owned wholesale grocery cooperative that supplies independently owned supermarkets and grocery stores. [1] It serves more than 4,000 locations in 36 states in the Midwest , the Southeast , and the Southwest , and from 8 full-line wholesale divisions.

6. Neurocrine Biosciences - Wikipedia

   en.wikipedia.org/wiki/Neurocrine_Biosciences

   Neurocrine Biosciences, Inc. is an American biopharmaceutical company founded in 1992. [1] It is headquartered in San Diego, California, and led by CEO Kevin Gorman. [3] ...

7. Why Is Neurocrine Biosciences Stock Trading Lower On Friday?

   www.aol.com/why-neurocrine-biosciences-stock...

   Ingrezza fourth quarter and fiscal 2024 net product sales were $615 million and $2.3 billion, respectively. ... Analyst Myles Minter writes that near-term pressures are weighing on the Ingrezza ...